🔗 Visit the ClinicalTrials.gov page for NCT01767194
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Advances in Risk Classification and Treatment Strategies for Neuroblastoma. | J Clin Oncol | 2015 | 1.19 |
| 2 | Trial Watch: Tumor-targeting monoclonal antibodies in cancer therapy. | Oncoimmunology | 2014 | 1.05 |
| 3 | New strategies in neuroblastoma: Therapeutic targeting of MYCN and ALK. | Clin Cancer Res | 2013 | 1.02 |
| 4 | Trial Watch: Immunostimulatory cytokines. | Oncoimmunology | 2013 | 0.96 |
| 5 | NK cell-based immunotherapies in Pediatric Oncology. | J Pediatr Hematol Oncol | 2015 | 0.85 |
| 6 | Immunotherapy in pediatric malignancies: current status and future perspectives. | Future Oncol | 2014 | 0.78 |
| 7 | Trial Watch-Immunostimulation with cytokines in cancer therapy. | Oncoimmunology | 2015 | 0.77 |
| 8 | Genetic discoveries and treatment advances in neuroblastoma. | Curr Opin Pediatr | 2016 | 0.77 |
| 9 | Advances in paediatric cancer treatment. | Transl Pediatr | 2014 | 0.76 |